For the Inventor, By the Inventor

Enter assignee name

Cassiopea S.p.a.

USPTO Granted Patents = 14

CIPO Patents = 4

EPO Patents = 5

Trademarks = 4

Forward Citations = 43

Loading Chart...

Loading Chart...

4 inventors (with patents filed for the assignee):

Luigi Moro (10 out of 32 patents)

Mauro Ajani (10 out of 44 patents)

Luigi Maria Longo (4 out of 16 patents)

4. Michael Albeck (36 patents)

5. Benjamin Sredni (32 patents)

6. Luigi Moro (0 patent)

14 patents: Sort by Forward Citations

1. 12337002 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2025-06-24),

2. 11938141 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2024-03-26),

3. 11883415 - High concentration formulation (2024-01-30),

4. 11213531 - High concentration formulation (2022-01-04),

5. 11207332 - Enzymatic process for obtaining 17 α-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2021-12-28),

6. 10980819 - High concentration formulation (2021-04-20),

7. 10716796 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2020-07-21),

8. 10603327 - High concentration formulation (2020-03-31),

9. 10166245 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2019-01-01),

10. 10159682 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2018-12-25),

11. 9895379 - 17alpha, 21-dihydroxypregnene esters as antiandrogenic agents (2018-02-20),

12. 9486458 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2016-11-08),

13. 9433628 - Enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2016-09-06),

14. 9211295 - 17 alpha, 21-dihydroxypregnene esters as antiandrogenic agents (2015-12-15),

Cassiopea S.p.a. is an innovative biopharmaceutical company based in Lainate, Italy, focused on developing and commercializing novel dermatological therapies. The company specializes in research and development of treatments for skin conditions, leveraging advanced technologies to address unmet medical needs. With a commitment to scientific excellence, Cassiopea aims to enhance patient outcomes through its proprietary formulations and clinical expertise, positioning itself as a key player in the global dermatology market.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

14 Patents

#3 in Lainate

#662 in Italy

#42,199 in the World

Cassiopea S.p.a.

Forward Citations = 43

4 inventors:

Luigi Moro (10 out of 32 patents)

Mauro Ajani (10 out of 44 patents)

Luigi Maria Longo (4 out of 16 patents)

4. Michael Albeck (36 patents)

5. Benjamin Sredni (32 patents)

Please report any incorrect information to [email protected]

Loading…